Modifying tetramethyl-nitrophenyl-imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy.

Modifying tetramethyl-nitrophenyl-imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy.
复制标题

DOI:
10.2147/dddt.s76218
复制
发表时间:
2015
期刊:
Drug design, development and therapy
影响因子:
--
通讯作者:
Peng S
Peng S
中科院分区:
其他
文献类型:
--
作者:
Jiang X;Wang Y;Zhu H;Wang Y;Zhao M;Zhao S;Wu J;Li S;Peng S

文献摘要

相似文献

通过药效团分析和对接研究,设计、合成了15种新型1-(4,4,5,5-四甲基-2-(3-硝基苯基)-4,5-二氢咪唑-1-基)-氧乙酰基- l氨基酸(6a-o),并进行了分析。在甩尾和二甲苯诱导的耳部水肿模型中,10 μmol/kg 6a-o具有良好的口服抗炎和镇痛活性。对其代表性的6f进行剂量依赖性测定,有效剂量为3.3 μmol/kg。将三维定量构效关系与对接分析相结合,为合理设计治疗炎症性疼痛的药物提供依据。
With the help of pharmacophore analysis and docking investigation, 15 novel 1-(4,4,5,5-tetramethyl-2-(3-nitrophenyl)-4,5-dihydroimidazol-1-yl)-oxyacetyl-L-amino acids (6a–o) were designed, synthesized, and assayed. On tail-flick and xylene-induced ear edema models, 10 μmol/kg 6a–o exhibited excellent oral anti-inflammation and analgesic activity. The dose-dependent assay of their representative 6f indicates that the effective dose should be 3.3 μmol/kg. The correlation of the three-dimensional quantitative structure–activity relationship with the docking analysis provides a basis for the rational design of drugs to treat inflammatory pain.